New briefing highlights actions to ensure access to best-practice heart failure care in Italy

News & Events

13 April 2023
AUTHOR: Ellen McIntosh

The latest policy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Italy.

Based on extensive research and expert interviews, the briefing  recommends specific actions, including:

The current health landscape in Italy means that the quality of care for people living with heart failure varies greatly across regions. However, the National Plan for Chronic Conditions does prioritise heart failure, providing an opportunity for advocacy groups to call for the Plan’s implementation in their area to address existing inequalities in care.

This briefing is the third in our From guidelines to action series, which aims to equip national advocates with a targeted analysis of the opportunities available in their countries, along with specific actions they can take to change the narrative in their region. All of the actions are supported by successful examples from a number of health interventions and interviews with national heart failure experts. The Italian briefing follows reports on France and Spain, with a German report due to be published soon.

Download the report in English

Download the report in Italian

Tagged:

More from News & Events

New briefing provides heart failure advocates with actionabl
New briefing provides heart failure advocates with actionabl...
15 May 2023
The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany. ...
Read article
Tackling the overlooked epidemic of heart failure in Germany
Tackling the overlooked epidemic of heart failure in Germany...
04 May 2023
Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comp...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .